71 related articles for article (PubMed ID: 3151316)
1. [Ps. aeruginosa lipopolysaccharide vaccine in the treatment of burns (report of 30 cases)].
Yu HX
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1988 Mar; 4(1):38-40. PubMed ID: 3151316
[No Abstract] [Full Text] [Related]
2. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
[No Abstract] [Full Text] [Related]
3. Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.
Jones RJ
J Hyg (Lond); 1979 Jun; 82(3):453-62. PubMed ID: 109501
[TBL] [Abstract][Full Text] [Related]
4. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
5. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
[No Abstract] [Full Text] [Related]
6. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
[No Abstract] [Full Text] [Related]
7. [Infection and immunity in burns].
Kolker II
Khirurgiia (Mosk); 1980 May; (5):17-22. PubMed ID: 6772869
[No Abstract] [Full Text] [Related]
8. Controlled trials of a polyvalent pseudomonas vaccine in burns.
Jones RJ; Roe EA; Gupta JL
Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
[TBL] [Abstract][Full Text] [Related]
9. [Effects of allogeneic anti-Bacillus pyocyaneus and anti-Proteus plasma humoral and cellular immunity in patients with severe burns].
Nazarchuk LV
Klin Khir; 1996; (5):29-31. PubMed ID: 8991678
[No Abstract] [Full Text] [Related]
10. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Moroz AF; Kharitonova AM; Chanturiia TsK
Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
[TBL] [Abstract][Full Text] [Related]
11. Whole cell heat-killed gram-negative bacilli vaccine.
Waisbren BA; Martins RR; Bruns WT; Kurzynski TA
Wis Med J; 1974 Apr; 73(4):S42-5. PubMed ID: 4206996
[No Abstract] [Full Text] [Related]
12. Active immunoprophylaxis in burns with a new multivalent vaccine.
Sachs A
Lancet; 1970 Nov; 2(7680):959-61. PubMed ID: 4097599
[No Abstract] [Full Text] [Related]
13. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.
Cryz SJ; Fürer E; Cross AS; Wegmann A; Germanier R; Sadoff JC
J Clin Invest; 1987 Jul; 80(1):51-6. PubMed ID: 3110215
[TBL] [Abstract][Full Text] [Related]
14. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
[No Abstract] [Full Text] [Related]
16. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S
Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737
[No Abstract] [Full Text] [Related]
17. Studies on burns. XI. Immunoglobulin and alpha 2 macroglobulin patterns and bacterial flora during treatment of burns with warm dry air.
Birke G; Liljedahl SO; Norberg R
Scand J Plast Reconstr Surg; 1969; 3(1):39-48. PubMed ID: 4188953
[No Abstract] [Full Text] [Related]
18. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas immunoglobulin and vaccine in burn patients.
Bose B
Lancet; 1981 Feb; 1(8217):435. PubMed ID: 6110056
[No Abstract] [Full Text] [Related]
20. Pseudomonas aeruginosa: prevention better than cure?
Mellor JA; Miler JJ
Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
